Mental health providers in Central Illinois offering ketamine say it has changed patients' lives for the better. Still, only ...

The FDA approval of esketamine (Spravato) in 2019 marked a watershed moment for glutamate-based treatments. As a derivative of ketamine, esketamine acts on NMDA receptors to produce rapid ...

Over the years, researchers increasingly investigated ketamine for its potential use in treating mental health conditions. In 2019, the Food and Drug Administration approved esketamine (Spravato ...

When Therapy Alone Isn't Enough, Options Like TMS and SPRAVATO® Provide Additional Relief OAK BROOK, Ill., April 8, 2025 /PRNewswire/ -- As we honor Counseling Awareness Month, Relief Mental Health ...

The FDA approval of esketamine (Spravato) in 2019 marked a watershed moment for glutamate-based treatments. As a derivative of ketamine, esketamine acts on NMDA receptors to produce rapid ...

A Cleveland Clinic psychiatrist explains how ketamine therapy is transforming depression treatment—and why it works when ...

Limitless provides immersive guided visualizations that help patients feel safe and anchored while leveraging the neuroplasticity created by ketamine. For patients undergoing Spravato (esketamine ...

Ketamine has long been seen as a potential ... who have cycled through multiple treatments without relief. Spravato (esketamine) has been touted as a potential blockbuster for Janssen, which ...

Picture: Neville Barrett / IMAS – A portion of the $1.8 billion spend over five years on new Pharamaceutical Benefit Scheme medications towards esketamine – a nasal spray ketamine for ...